APOLIPOPROTEIN B
Determination of apolipoprotein B (Apo B) level in human serum and plasma is used to assess the risk of heart disease (especially ischemic heart disease) on the atherosclerotic basis. Increased level of Apo B is observed in hyperlipidemia, coronary heart disease, diabetes, hypothyroidism, nephrotic syndrome, chronic renal failure, liver disease, biliary obstruction and Cushing's syndrome. A decrease in the concentration of Apo B occurs in hyperthyroidism, chronic anemia, malnutrition, intestinal malabsorption, inflammation and infections, Tangier disease.
Specification
Method |
Immunoturbidimetric |
Specimen |
serum, plasma |
On board stability |
N/A |
Calibration stability |
N/A |
Measuring range |
0,019 – 4 g/l |
Regulatory status |
CE IVD |
Reagent lines
Multipurpose Line
ACCENT-200
ACCENT-300
A-400
A-800
Prestige 24i
Prestige 24i APOLIPOPROTEIN B (24 positions reagent tray)
Prestige 24i APOLIPOPROTEIN B (36 positions reagent tray)OS
Panels: cardiac, lipids, specific proteins
Available reagents
A-800 APOLIPOPROTEIN B
ACCENT-200 APOLIPOPROTEIN B
ACCENT-300 APOLIPOPROTEIN B
CORMAY APOLIPOPROTEIN B
OS-APOLIPOPROTEIN B
PRESTIGE 24i APOLIPOPROTEIN B
The specification was based on data determined on selected analyzers. We recommend that all users should refer to the instruction for use (IFU) and instruments’ user or service manuals before proceeding.
Order this product
To order this product, please contact your Area Sales Manager for details. If you have any questions, click the button below and fill out the form. We will contact you as soon as possible.